{'Year': '2012', 'Month': 'Apr'}
Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19.
Our purpose was to investigate the feasibility of pharmacy-initiated pharmacogenetic (PGt) screening in primary care with respect to patient willingness to participate, quality of DNA collection with saliva kits, genotyping, and dispensing data retrieved from the pharmacy.